ANP/NPRA signaling preferentially mediates Th2 responses in favor of pathological processes during the course of acute allergic asthma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 5121-5128

  Ma, Libing ^a,b   Zeng, Jinrong ^a,b   Mo, Biwen ^a,b   Wang, Changming ^a,b   Sun, Yabing ^a,b   Zhang, Meng ^e   Liu, Shaokun ^d   Xiang, Xudong ^c,d   Wang, Cong Yi ^c,d,e  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Respiratory Diseases of Colleges and Universities Affiliated Education Department of Guangxi Zhuang Autonomous Region   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute allergic asthma; Airway inflammation; Atrial natriuretic peptide Natriuretic peptide receptor A (ANP NPRA) signaling; Th1 Th2 cells

Indexed keywords

A71915; ATRIAL NATRIURETIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; NATRIURETIC PEPTIDE RECEPTOR A; RECEPTOR BLOCKING AGENT; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LUNG HOMOGENATE; LUNG LAVAGE; LYMPHOCYTE COUNT; MOUSE; MUCUS SECRETION; NEUTROPHIL COUNT; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

MUS;

EID: 84931282074     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. [1] Ngoc PL, Gold DR, Tzianabos AO, Weiss ST and Celedon JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005; 5: 161-166.
2. [2] Umetsu DT, McIntire JJ, Akbari O, Macaubas C and DeKruyff RH. Asthma: an epidemic of dys regulated immunity. Nat Immunol 2002; 3: 715-720.
3. [3] Vesely DL. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 2001; 51: 647-658.
4. [4] Silberbach M and Roberts CT Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 2001; 13: 221-231.
5. [5] Perreault T and Gutkowska J. Role of atrial natriuretic factor in lung physiology and pathology. Am J Respir Crit Care Med 1995; 151: 226-242.
6. [6] Mohapatra SS. Role of natriuretic peptide signaling in modulating asthma and inflammation. Can J Physiol Pharmacol 2007; 85: 754-759.
7. [7] Misono KS. Natriuretic peptide receptor: structure and signaling. Mol Cell Biochem 2002; 230: 49-60.
8. [8] De Vito P. Atrial natriuretic peptide: an old hormone or a new cytokine? Peptides 2014; 58: 108-116.
9. [9] Ma L, Li J, Wang G, Gong S, Zhang L, Li K, Ji X, Liu Y, Chen P and Xiang X. Atrial natriuretic peptide suppresses Th17 development through regulation of cGMP-dependent protein kinase and PI3K-Akt signaling pathways. Regul Pept 2013; 181: 9-16.
10. [10] Ma L and Xiang X. Atrial natriuretic peptide/natriuretic peptide receptor A (ANP/NPRA) signaling pathway: a potential therapeutic target for allergic asthma. Med Hypotheses 2011; 77: 832-833.
11. [11] McMillan SJ and Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004; 34: 497-507.
12. [12] Yang P, Zhang Y, Pang J, Zhang S, Yu Q, He L, Wagner KU, Zhou Z and Wang CY. Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities. Am J Pathol 2013; 183: 617-625.
13. [13] Yang P, Zhang Y, Xu J, Zhang S, Yu Q, Pang J, Rao X, Kuczma M, Marrero MB, Fulton D, Kraj P, Su Y and Wang CY. SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses. Am J Transl Res 2013; 5: 427-440.
14. [14] Zhong J, Yu Q, Yang P, Rao X, He L, Fang J, Tu Y, Zhang Z, Lai Q, Zhang S, Kuczma M, Kraj P, Xu JF, Gong F, Zhou J, Wen L, Eizirik DL, Du J, Wang W and Wang CY. MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. J Autoimmun 2014; 53: 95-104.
15. [15] Tu Y, Yu Q, Fan G, Yang P, Lai Q, Yang F, Zhang S, Wang W, Wang D, Yu X and Wang CY. Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses. Mol Cell Endocrinol 2014; 396: 1-9.
16. [16] Tallerico-Melnyk T, Yip CC and Watt VM. Widespread co-localization of mRNAs encoding the guanylate cyclase-coupled natriuretic peptide receptors in rat tissues. Biochem Biophys Res Commun 1992; 189: 610-616.
17. [17] Chrisman TD, Schulz S, Potter LR and Garbers DL. Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem 1993; 268: 3698-3703.
18. [18] Deschepper CF and Picard S. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors. J Neurochem 1994; 62: 1974-1982.
19. [19] Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y and Imura H. Vascular natriuretic peptide. Lancet 1992; 340: 622.
20. [20] Panchenko MP, Joyce-Brady M, Starikova MG, Oakes SM, Adachi R, Brody JS and Dickey BF. Atrial natriuretic peptide modulates alveolar type 2 cell adenylyl and guanylyl cyclases and inhibits surfactant secretion. Biochim Biophys Acta 1998; 1403: 115-125.
21. [21] De Vito P, Incerpi S, Pedersen JZ and Luly P. Atrial natriuretic peptide and oxidative stress. Peptides 2010; 31: 1412-1419.
22. [22] Vollmar AM. The role of atrial natriuretic peptide in the immune system. Peptides 2005; 26: 1086-1094.
23. [23] Chujo K, Ueki M, Asaga T and Taie S. Atrial natriuretic peptide attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats. Tohoku J Exp Med 2008; 215: 257-266.
24. [24] Morita R, Ukyo N, Furuya M, Uchiyama T and Hori T. Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A. J Immunol 2003; 170: 5869-5875.
25. [25] Umetsu DT and DeKruyff RH. The regulation of allergy and asthma. Immunol Rev 2006; 212: 238-255.